An array of blue-chip global fund managers have adjusted their fundraising strategies for China, collecting their latest batch of dry powder in the local currency or renminbi (RMB) to back their bets on the market despite concerns that the country may be losing its growth momentum over COVID contraction and geopolitical risks.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
